VESANOID Reviews (TRETINOIN)Average Rating: 5.0 (1 Ratings)Filter ResultsCompare VESANOID with similar:
Type: Brand name discontinued; available as generic
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR VESANOID | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
5 | APL Leukemia | None at first, but severe headaches over time. Dizziness and blurred visions. On a positive note, it made my skin texture amazing. Smooth, even, glowing. Strangers would comment on it. | I was taking this drug in the pill form to treat my Leukemia (APL) between 2008 and 2010. I was on it off and on for about 18 months in addition to traditional chemo. I am in remission and have been for a few years. In the beginning, when my cancer was progressing agressively, this pill did not have any side effects for me and appeared to be working as intended. Once I went into remission and no signs of cancer remained, I continued taking it per my oncologist to stay in remisison as "maintainence". It was then that I began to experience really bad side effects of the headaches, dizziness and blurred vision, to the point where I could hardly function normally and driving was dangerous. It was rough, but went away completely a few days after I finished my dose. As mentioned, it did improve my skin considerably and I looked 10 years younger but that stopped when I went off the drug as well. Overall, of course I'm satisfied, as now I'm cancer free! | F | 30 | 18 months 2X day | 10/23/2011 |
VESANOID (TRETINOIN): A retinoid indicated for induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL), characterized by presence of t(15;17) translocation or presence of PML/RARa gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated FDA Approval Date: 1995-11-22 (Sources: U.S. Centers for Medicare Services, FDA)